Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03906318
Expanded Access Status : Available
First Posted : April 8, 2019
Last Update Posted : July 19, 2021
Information provided by (Responsible Party):
Incyte Corporation

Brief Summary:
Expanded access use of Itacitinib to treat a single patient with aplastic anemia.

Drug: Itacitinib

Layout table for study information
Study Type : Expanded Access
Expanded Access Type : Individual Patients
  See clinical trials of the intervention/treatment in this expanded access record.

Intervention Details:
  • Drug: Itacitinib
    Other Name: INCB039110

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult

Inclusion Criteria:


Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03906318

Layout table for location contacts
Contact: Incyte Corporation Call Center (US) 1.855.463.3463

Sponsors and Collaborators
Incyte Corporation
Layout table for investigator information
Principal Investigator: Lisa Forbes Satter, MD Baylor College of Medicine - Texas Children's Hospital
Layout table for additonal information
Responsible Party: Incyte Corporation Identifier: NCT03906318    
Other Study ID Numbers: I-39110-18-05
First Posted: April 8, 2019    Key Record Dates
Last Update Posted: July 19, 2021
Last Verified: July 2021